Archive for the ‘Ambit Biosciences’ Category

Ambit Biosciences

October 11th, 2013 | Posted in 2013, Ambit Biosciences

Ambit Biosciences – San Diego:  Founded in 2000, and publically traded since May of this year, the company appears close to the first approval of its drug for blood cancer.  Dr. Gant Liu is Senior Director of Chemistry.  Michael A. Martino is President and CEO.  Called Quizartnib, the drug treats acute myeloid leukemia.